Clinical trial
Characterization of Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes in Adult Patients With Idiopathic Recurrent and Chronic Cholestasis in Spain - REGENIC
NCT07191704 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes in Adult Patients With Idiopathic Recurrent and Chronic Cholestasis in Spain - REGENIC
- Lead sponsor
- Ipsen
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 8, 2025
- Completion date
- June 3, 2026
- Enrollment
- 150 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
pfic - progressive familial intrahepatic cholestasis